Quick answers
- What is Solucion InterSol?
- Solucion InterSol is a brand name of Platelet additive 3 (sodium acetate / sodium chloride / sodium phosphate, dibasic, unspecified form / sodium phosphate, monobasic, monohydrate / trisodium citrate dihydrate), a prescription medicine. The FDA NDC Directory lists 1 Solucion InterSol product in 1 strength and form.
- Who makes Solucion InterSol?
- Fenwal, Inc. lists 1 of the 1 Solucion InterSol products in the FDA NDC Directory.
- Is there a generic or store brand of Solucion InterSol?
- Yes. The FDA NDC Directory lists 2 other products with the same active ingredients, strength and form as a Solucion InterSol product. Ask your pharmacist whether one is right for you.
- Has Solucion InterSol been recalled?
- No recall linked to Solucion InterSol products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Solucion InterSol is
Each Solucion InterSol product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Platelet additive 3 (sodium acetate / sodium chloride / sodium phosphate, dibasic, unspecified form / sodium phosphate, monobasic, monohydrate / trisodium citrate dihydrate) · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| sodium acetate 442 mg/100 mL · sodium chloride 452 mg/100 mL · sodium phosphate, dibasic, unspecified form 305 mg/100 mL · sodium phosphate, monobasic, monohydrate 93 mg/100 mL · trisodium citrate dihydrate 318 mg/100 mL solution (intravenous) | Solucion InterSol | 2 products, 1 company | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Platelet additive 3 (sodium acetate / sodium chloride / sodium phosphate, dibasic, unspecified form / sodium phosphate, monobasic, monohydrate / trisodium citrate dihydrate) →
FDA approval
No Drugs@FDA application is linked to these products.
Companies that list Solucion InterSol
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Solucion InterSol products.
- Fenwal, Inc.1 product
Recalls
No recall linked to Solucion InterSol products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.